Monotherapy of B21 mAb or cisplatin considerably reduced the growth of A2780 ovarian cancer-bearing mice compared to the mice bearing A2780 ovarian cancer stimulated with OSM or control IgG (Fig. 5b, c). This evidence concerns the gene CYTH1 and ovarian cancer.